Is ImmunoGen, Inc. (IMGN) a Buy, Sell, or Hold?
NASDAQ : IMGN
ImmunoGen, Inc.
$31.235 USD
$0.01 (0.02%)
- Volume
- 19.31M
- Average Volume
- 9.19M
- Market Capitalization
- $8.73B
- P/E Ratio
- -35.54
- Dividend Yield
- 0.00%
- Price Target
- $16.00
- Year High
- $31.25
- Year Low
- $3.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.26
Analyst Consensus Summary
Consensus Rating
N/A
22 Analysts
Rating Score
0/5
Recommendation Strength
Upside/Downside
95.2%
vs Current Price
Price Target
$16.00
Average TargetPrice Target Range
Lowest Target
$6.36
391.1% UPSIDE
Average Target
$16.00
Median Estimate
Highest Target
$22.00
42.0% UPSIDEAnalyst Breakdown
Overall Consensus: Hold | Total Analysts: 22
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 6 | 15 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| J.P. Morgan | Brian Cheng | $22 | $16.155 | 2023-09-13 09:55 AM | 36.2% |
| Piper Sandler | Joseph Catanzaro | $16 | $12.26 | 2023-05-03 07:33 AM | 30.5% |
| Barclays | Peter Lawson | $6.36 | $5.76 | 2022-11-15 02:26 AM | 10.4% |
| Piper Sandler | Joseph Catanzaro | $6.5 | $6.17 | 2021-11-29 07:00 PM | 5.3% |